Overview

A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this trial is to understand if adding saxagliptin to metformin therapy is safe and works better than taking either saxagliptin or metformin alone
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AstraZeneca
Treatments:
Metformin
Pioglitazone
Saxagliptin
Criteria
Inclusion Criteria:

- Type 2 diabetes

- Inadequate blood sugar control

- No current treatment with other medications to lower blood sugar

Exclusion Criteria:

- Major heart, liver or kidney problems

- Pregnant or breast feeding